Association of Glycogen Synthase Phosphatase And
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Effects of Acute Nicotinamide Riboside Supplementation
THE EFFECTS OF ACUTE NICOTINAMIDE RIBOSIDE SUPPLEMENTATION ON SUBSTRATE UTILISATION AND 5KM TIME-TRIAL PERFORMANCE By ELIZABETH LOUISE GRAY A thesis submitted to The University of Birmingham for the degree of MASTERS BY RESEARCH School of Sport, Exercise and Rehabilitation Sciences College of Life and Environmental Studies University of Birmingham August 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Nicotinamide Riboside (NR) administration has been shown to increase fat oxidation and improve endurance performance in rodents, whilst recent research has proven it is safe for human consumption. The present study aimed to investigate the influence of acute NR supplementation on substrate utilisation and exercise performance in humans. In this counter-balanced, crossover design study, eleven recreationally-active males performed a 60-minute bout of cycling at 55% VO2max, followed by a 5km time-trial. Participants completed this twice during visits separated by at least one week, once following the consumption of 1000mg NR, and the other following placebo consumption. The contribution of fat oxidation to total substrate utilisation was not significantly different between the NR and placebo conditions during steady-state exercise (22.3±9.0% and 19.6±7.3%, respectively; p < 0.05). -
Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones
ORIGINAL RESEARCH published: 12 December 2018 doi: 10.3389/fphys.2018.01786 Dynamic Metabolic Zonation of the Hepatic Glucose Metabolism Is Accomplished by Sinusoidal Plasma Gradients of Nutrients and Hormones Nikolaus Berndt 1,2 and Hermann-Georg Holzhütter 1* 1 Computational Biochemistry Group, Institute of Biochemistry, Charite—University Medicine Berlin, Berlin, Germany, 2 Institute for Computational and Imaging Science in Cardiovascular Medicine, Charite—University Medicine Berlin, Berlin, Germany Being the central metabolic organ of vertebrates, the liver possesses the largest repertoire of metabolic enzymes among all tissues and organs. Almost all metabolic pathways are resident in the parenchymal cell, hepatocyte, but the pathway capacities may largely differ depending on the localization of hepatocytes within the liver acinus-a phenomenon that is commonly referred to as metabolic zonation. Metabolic zonation is rather dynamic since gene expression patterns of metabolic enzymes may change in response to nutrition, Edited by: drugs, hormones and pathological states of the liver (e.g., fibrosis and inflammation). Steven Dooley, Universitätsmedizin Mannheim, This fact has to be ultimately taken into account in mathematical models aiming at Medizinische Fakultät Mannheim, the prediction of metabolic liver functions in different physiological and pathological Universität Heidelberg, Germany settings. Here we present a spatially resolved kinetic tissue model of hepatic glucose Reviewed by: metabolism which includes zone-specific temporal changes of enzyme abundances Adil Mardinoglu, Chalmers University of Technology, which are driven by concentration gradients of nutrients, hormones and oxygen along Sweden the hepatic sinusoids. As key modulators of enzyme expression we included oxygen, Rolf Gebhardt, Leipzig University, Germany glucose and the hormones insulin and glucagon which also control enzyme activities *Correspondence: by cAMP-dependent reversible phosphorylation. -
The Role of Sirtuin 2 Activation by Nicotinamide Phosphoribosyltransferase in the Aberrant Proliferation and Survival of Myeloid Leukemia Cells
Acute Myeloid Leukemia Articles and Brief Reports The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells Lan Dan, 1,4 Olga Klimenkova, 1 Maxim Klimiankou, 1 Jan-Henning Klusman, 2 Marry M. van den Heuvel-Eibrink, 3 Dirk Reinhardt, 2 Karl Welte, 1 and Julia Skokowa 1 1Department of Molecular Hematopoiesis, Children’s Hospital, Hannover Medical School, Hannover, Germany; 2Department of Pediatric Hematology and Oncology, Children’s Hospital, Hannover Medical School, Hannover, Germany; and 3Department of Pediatric Oncology and Hematology, Erasmus MC-Sophia Children’s Hospital, Rotterdam, The Netherlands; 4Department of Pediatrics, The First Affiliated Hospital of GuangXi Medical University, NanNing, China ABSTRACT Acknowledgments: we thank Background A. Gigina, A. Müller Brechlin Inhibitors of nicotinamide phosphoribosyltransferase have recently been validated as therapeu - and M. Reuter for their excellent tic targets in leukemia, but the mechanism of leukemogenic transformation downstream of this technical assistance. enzyme is unclear. Manuscript received on Design and Methods September 14, 2011. Revised version arrived on November 21, Here, we evaluated whether nicotinamide phosphoribosyltransferase’s effects on aberrant pro - 2011. Manuscript accepted liferation and survival of myeloid leukemic cells are dependent on sirtuin and delineated the on December 19, 2011. downstream signaling pathways operating during this process. Correspondence: Results Karl Welte, Department of We identified significant upregulation of sirtuin 2 and nicotinamide phosphoribosyltransferase Molecular Hematopoiesis, Hannover levels in primary acute myeloid leukemia blasts compared to in hematopoietic progenitor cells Medical School, Carl-Neuberg from healthy individuals. Importantly, specific inhibition of nicotinamide phosphoribosyltrans - Str. 1, 30625 Hannover, ferase or sirtuin 2 significantly reduced proliferation and induced apoptosis in human acute Germany. -
Chem331 Glycogen Metabolism
Glycogen metabolism Glycogen review - 1,4 and 1,6 α-glycosidic links ~ every 10 sugars are branched - open helix with many non-reducing ends. Effective storage of glucose Glucose storage Liver glycogen 4.0% 72 g Muscle glycogen 0.7% 245 g Blood Glucose 0.1% 10 g Large amount of water associated with glycogen - 0.5% of total weight Glycogen stored in granules in cytosol w/proteins for synthesis, degradation and control There are very different means of control of glycogen metabolism between liver and muscle Glycogen biosynthetic and degradative cycle Two different pathways - which do not share enzymes like glycolysis and gluconeogenesis glucose -> glycogen glycogenesis - biosynthetic glycogen -> glucose 1-P glycogenolysis - breakdown Evidence for two paths - Patients lacking phosphorylase can still synthesize glycogen - hormonal regulation of both directions Glycogenolysis (glycogen breakdown)- Glycogen Phosphorylase glycogen (n) + Pi -> glucose 1-p + glycogen (n-1) • Enzyme binds and cleaves glycogen into monomers at the end of the polymer (reducing ends of glycogen) • Dimmer interacting at the N-terminus. • rate limiting - controlled step in glycogen breakdown • glycogen phosphorylase - cleavage of 1,4 α glycosidic bond by Pi NOT H2O • Energy of phosphorolysis vs. hydrolysis -low standard state free energy change -transfer potential -driven by Pi concentration -Hydrolysis would require additional step s/ cost of ATP - Think of the difference between adding a phosphate group with hydrolysis • phosphorylation locks glucose in cell (imp. for muscle) • Phosphorylase binds glycogen at storage site and the catalytic site is 4 to 5 glucose residues away from the catalytic site. • Phosphorylase removes 1 residue at a time from glycogen until 4 glucose residues away on either side of 1,6 branch point – stericaly hindered by glycogen storage site • Cleaves without releasing at storage site • general acid/base catalysts • Inorganic phosphate attacks the terminal glucose residue passing through an oxonium ion intermediate. -
Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency
Pediat. Res. 15: 299-303 (198 1) genetics muscle glycogenosis phosphorylase kinase deficiency liver Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency N. BASHAN. T. C. IANCU. A. LERNER. D. FRASER, R. POTASHNIK. AND S. W. MOSES'"' Pediatric Research Laborarorv. Soroka Medical Center. Iaculr~of Health Sciences. Ben-Gurion Universi!,' of Negev. Beer-Sheva, and Department of Pediatrics. Carmel Hospiral. Huifa. Israel Summary hepatomegaly. The family history disclosed that two sisters were similarly affected, whereas one older brother was apparently A four-year-old Israeli Arab boy was found to have glycogen healthy. accumulation in both liver and muscle without clinical symptoms. Past history was unremarkable. The patient's height was below Liver phosphorylase kinase (PK) activity was 20% of normal, the third percentile for his age in contrast to a normal weight. He resulting in undetectable activity of phosphorylase a. Muscle PK had a doll face and a protuberant abdomen. The liver was palpable activity was about 25% of normal, resulting in a marked decrease 9 cm below the costal margin. Slight muscular hypotonia and of phosphorylase a activity. weakness were noticeable with normal tendon reflexes. He had Two sisters showed a similar pattern, whereas one brother had slightly abnormal liver function tests. a fasting blood sugar of 72 normal PK activity. The patient's liver protein kinase activity was mg %, a normal glucagon test. and no lactic acidemia or uricemia normal. Addition of exogenous protein kinase did not affect PK but slight lipidemia. Electronmicroscopic studies of a liver biopsy activity, whereas exogenous PK restored phosphorylase activity revealed marked deposition of glycogen. -
UNIVERSITY of CALIFORNIA, SAN DIEGO Mechanism of Pentose
UNIVERSITY OF CALIFORNIA, SAN DIEGO Mechanism of Pentose Phosphate Pathway Regulation by Akt in de Novo Purine Synthesis During Essential Amino Acid Starvation A thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Biology by Deron Trent Amador Committee in charge: Professor Gerard Boss, Chair Professor Eliña Zuniga, Co-Chair Professor Elvira Tour 2012 The Thesis of Deron Trent Amador is approved and it is acceptable in quality and form for publication on microfilm and electronically: ____________________________________________________________________ ____________________________________________________________________ ____________________________________________________________________ Chair University of California, San Diego 2012 iii TABLE OF CONTENTS Signature Page……………………………………………………………………... iii Table of Contents…………………………………………………………….......... iv List of Figures…………………………………………………………………….… v Abstract……………………………………………………………………………... vii Introduction……………………………………………………………………….… 1 Experimental Procedures……………………………………………………….… 16 Results……………………………………………………………………………… 20 Discussion……………………………………………………………………….…. 32 References……………………………………………………………………….… 36 iv LIST OF FIGURES Figure 1: General schematic diagram of the phosphatidylinositol 3-kinase/Akt signal transduction pathway with targets of Akt and resulting cellular processes.. 3 Figure 2: Schemaric diagram of the non-oxidative branch of the pentose phosphate pathway…………………………………………………………………………… 6 Figure 3: Schematic diagram of the -
Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease
cells Review Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease Marta Migocka-Patrzałek * and Magdalena Elias Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wroclaw, 50-335 Wroclaw, Poland; [email protected] * Correspondence: [email protected] Abstract: Glycogen phosphorylase (PG) is a key enzyme taking part in the first step of glycogenolysis. Muscle glycogen phosphorylase (PYGM) differs from other PG isoforms in expression pattern and biochemical properties. The main role of PYGM is providing sufficient energy for muscle contraction. However, it is expressed in tissues other than muscle, such as the brain, lymphoid tissues, and blood. PYGM is important not only in glycogen metabolism, but also in such diverse processes as the insulin and glucagon signaling pathway, insulin resistance, necroptosis, immune response, and phototransduction. PYGM is implicated in several pathological states, such as muscle glycogen phosphorylase deficiency (McArdle disease), schizophrenia, and cancer. Here we attempt to analyze the available data regarding the protein partners of PYGM to shed light on its possible interactions and functions. We also underline the potential for zebrafish to become a convenient and applicable model to study PYGM functions, especially because of its unique features that can complement data obtained from other approaches. Keywords: PYGM; muscle glycogen phosphorylase; functional protein partners; glycogenolysis; McArdle disease; cancer; schizophrenia Citation: Migocka-Patrzałek, M.; Elias, M. Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease. Cells 1. Introduction 2021, 10, 883. https://doi.org/ The main energy substrate in animal tissues is glucose, which is stored in the liver and 10.3390/cells10040883 muscles in the form of glycogen, a polymer consisting of glucose molecules. -
Rats Genetically Selected for High Aerobic Exercise Capacity
antioxidants Article Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1 1, , 2, 2 3 Terry D. Hinds Jr. * y , Justin F. Creeden y, Darren M. Gordon , Adam C. Spegele , Steven L. Britton 4, Lauren G. Koch 3 and David E. Stec 5,* 1 Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, KY 40508, USA 2 Department of Neurosciences, University of Toledo College of Medicine, Toledo, OH 43614, USA; [email protected] (J.F.C.); [email protected] (D.M.G.) 3 Department of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH 43614, USA; [email protected] (A.C.S.); [email protected] (L.G.K.) 4 Department of Anesthesiology, Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA; [email protected] 5 Center for Excellence in Cardiovascular-Renal Research, Department of Physiology & Biophysics, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 392161, USA * Correspondence: [email protected] (T.D.H.J.); [email protected] (D.E.S.) Authors contributed equally. y Received: 24 August 2020; Accepted: 16 September 2020; Published: 19 September 2020 Abstract: Exercise in humans and animals increases plasma bilirubin levels, but the mechanism by which this occurs is unknown. In the present study, we utilized rats genetically selected for high capacity running (HCR) and low capacity running (LCR) to determine pathways in the liver that aerobic exercise modifies to control plasma bilirubin. -
Lehrstuhl Für Technische Mikrobiologie Sucrose Metabolism
Lehrstuhl für Technische Mikrobiologie Sucrose metabolism in lactobacilli and bifidobacteria Susanne B. Kaditzky Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr.-Ing., Dr.-Ing. habil. Werner Back Prüfer der Dissertation: 1. Univ.-Prof. Dr. rer. nat. habil. Rudi F. Vogel 2. Univ.-Prof. Dr. rer. nat. habil. Siegfried Scherer 3. Ass. Prof. Dr. rer. nat. Michael Gänzle, University of Alberta / Kanada (schriftliche Beurteilung) Die Dissertation wurde am 25.10.2007 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 07.01.2008 angenommen. Lehrstuhl für Technische Mikrobiologie Sucrose metabolism in lactobacilli and bifidobacteria Susanne B. Kaditzky Doctoral thesis Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt Freising 2008 Mein Dank gilt Rudi Vogel für die Überlassung des Themas und seine geduldige und unterstützende Begleitung durch die lehrreichen und interessanten Jahre, Michael Gänzle, Maher Korakli und Daniel Meissner für ihr Engagement und ihre Unterstützung, allen Kollegen für das gute und humorvolle Arbeitsklima, Andreas Stocker für die Charakterisierung des EPS mit FFF, Peter Kaden für die NMR- Analyse und Jürgen Behr für die Durchführung der 2D-Experimente, -
Activation of the AMPK/Sirt1 Pathway by a Leucine
METABOLISM CLINICAL AND EXPERIMENTAL 65 (2016) 1679– 1691 Available online at www.sciencedirect.com Metabolism www.metabolismjournal.com Activation of the AMPK/Sirt1 pathway by a leucine–metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans Jheelam Banerjee⁎, Antje Bruckbauer, Michael B. Zemel NuSirt BioPharma Inc., 11020 Solway School Road, Knoxville, TN 37931, USA ARTICLE INFO ABSTRACT Article history: Background. We have previously shown leucine (Leu) to activate Sirt1 by lowering its KM for Received 28 January 2016 NAD+, thereby amplifying the effects of other sirtuin activators and improving insulin Accepted 29 June 2016 sensitivity. Metformin (Met) converges on this pathway both indirectly (via AMPK) and by direct activation of Sirt1, and we recently found Leu to synergize with Met to improve insulin Keywords: sensitivity and glycemic control while achieving ~80% dose-reduction in diet-induced obese AMPK mice. Accordingly, we sought here to define the mechanism of this interaction. Sirt1 Methods. Muscle cells C2C12 and liver cells HepG2 were used to test the effect of Met–Leu on Insulin sensitivity Sirt1 activation. Caenorhabditis elegans was used for glucose utilization and life span studies. Leucine Results. Leu (0.5 mmol/L) + Met (50–100 μmol/L) synergistically activated Sirt1 (p < 0.001) at + Metformin low (≤100 μmol/L) NAD levels while Met exerted no independent effect. This was associated with an increase in AMPK and ACC, phosphorylation, and increased fatty acid oxidation, which was prevented by AMPK or Sirt inhibition or silencing. Met–Leu also increased P-IRS1/IRS1 and P-AKT/AKT and in insulin-independent glucose disposal in myotubes (~50%, p < 0.002) evident within 30 min as well as a 60% reduction in insulin EC50. -
O-Glcnacylation Is a Key Regulator of Multiple Cellular Metabolic Pathways
O-GlcNAcylation is a key regulator of multiple cellular metabolic pathways Hongshuo Zhang, Zhen Li, Yufei Wang and Ying Kong Core Laboratory of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China ABSTRACT O-GlcNAcylation modifies proteins in serine or threonine residues in the nucleus, cytoplasm, and mitochondria. It regulates a variety of cellular biological processes and abnormal O-GlcNAcylation is associated with diabetes, cancer, cardiovascular disease, and neurodegenerative diseases. Recent evidence has suggested that O-GlcNAcylation acts as a nutrient sensor and signal integrator to regulate metabolic signaling, and that dysregulation of its metabolism may be an important indicator of pathogenesis in disease. Here, we review the literature focusing on O-GlcNAcylation regulation in major metabolic processes, such as glucose metabolism, mitochondrial oxidation, lipid metabolism, and amino acid metabolism. We discuss its role in physiological processes, such as cellular nutrient sensing and homeostasis maintenance. O-GlcNAcylation acts as a key regulator in multiple metabolic processes and pathways. Our review will provide a better understanding of how O-GlcNAcylation coordinates metabolism and integrates molecular networks. Subjects Biochemistry, Cell Biology, Metabolic Sciences Keywords O-GlcNAc, Nutrient sensing, Glucose uptake, Glycolysis, Mitochondria, Lipid metabolism, Glutamine, Signaling pathway, Homeostasis, TCA INTRODUCTION Increasing evidence has suggested -
Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly
International Journal of Molecular Sciences Article Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly 1,2, 3, 1,2, Alessandra Bolotta y, Giuseppe Filardo y, Provvidenza Maria Abruzzo *, Annalisa Astolfi 4,5 , Paola De Sanctis 1, Alessandro Di Martino 6, Christian Hofer 7, Valentina Indio 4 , Helmut Kern 7, Stefan Löfler 7 , Maurilio Marcacci 8, Sandra Zampieri 9,10, 1,2, 1, Marina Marini z and Cinzia Zucchini z 1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna School of Medicine, 40138 Bologna, Italy; [email protected] (A.B.); [email protected] (P.D.S.); [email protected] (M.M.); [email protected] (C.Z.) 2 IRCCS Fondazione Don Carlo Gnocchi, 20148 Milan, Italy 3 Applied and Translational Research Center, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; g.fi[email protected] 4 Giorgio Prodi Interdepartimental Center for Cancer Research, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy; annalisa.astolfi@unibo.it (A.A.); [email protected] (V.I.) 5 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy 6 Second Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; [email protected] 7 Ludwig Boltzmann Institute for Rehabilitation Research, 1160 Wien, Austria; [email protected] (C.H.); [email protected] (H.K.); stefan.loefl[email protected] (S.L.) 8 Department of Biomedical Sciences, Knee Joint Reconstruction Center, 3rd Orthopaedic Division, Humanitas Clinical Institute, Humanitas University, 20089 Milan, Italy; [email protected] 9 Department of Surgery, Oncology and Gastroenterology, University of Padua, 35122 Padua, Italy; [email protected] 10 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy * Correspondence: [email protected]; Tel.: +39-051-2094122 These authors contributed equally to this work.